title: Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunction.
authors.affiliation: Hematologic Malignancies and Blood and Marrow Transplant Program, Division of Medical Oncology, University of Colorado Cancer Center, USA. robert.chen@uchsc.edu
authors.forename: Robert
authors.initials: R
authors.lastname: Chen
authors.forename: Brian L
authors.initials: BL
authors.lastname: Abbott
authors.forename: Han
authors.initials: H
authors.lastname: Myint
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002051:Burkitt Lymphoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D015251:Epirubicin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone